Preclinical research is a crucial step toward the development of efficient anticancer treatments.
The preclinical testing of metronomic treatments for children in developing countries is an important issue. These children often present with advanced metastatic disease that our model should reproduce.
Children are also frequently suffering from denutrition which should be taken into account
to evaluate the tolerance of treatments.